BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$2.76B |
| 2 |
Analog Devices
ADI
|
+$2.38B |
| 3 |
Amazon
AMZN
|
+$2.01B |
| 4 |
Tesla
TSLA
|
+$1.68B |
| 5 |
Snowflake
SNOW
|
+$1.58B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$3.21B |
| 2 |
MXIM
Maxim Integrated Products
MXIM
|
+$2.54B |
| 3 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$1.28B |
| 4 |
Alibaba
BABA
|
+$1.25B |
| 5 |
WORK
Slack Technologies, Inc.
WORK
|
+$1.15B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.12% |
| 2 | Healthcare | 13.68% |
| 3 | Financials | 13.15% |
| 4 | Consumer Discretionary | 11.13% |
| 5 | Communication Services | 8.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3601
LiveOne
LVO
$59.4M
| $10.8M | ﹤0.01% |
360,612
+18,395
| +5% | +$637K |
|
3602
KVH Industries
KVHI
$143M
| $10.7M | ﹤0.01% |
1,114,354
-73,255
| -6% | -$795K |
|
3603
Oil-Dri
ODC
$1.27B
| $10.7M | ﹤0.01% |
613,246
+932
| +0.2% | +$16.3K |
|
|
CAN
3604
Canaan Creative
CAN
$159M
| $10.7M | ﹤0.01% |
1,753,814
+160,010
| +10% | +$1.24M |
|
3605
Escalade
ESCA
$287M
| $10.7M | ﹤0.01% |
566,155
-38,728
| -6% | -$858K |
|
|
TEAD
3606
Teads Holding Co
TEAD
$63.6M
| $10.7M | ﹤0.01% |
+719,837
| New | +$12.7M |
|
3607
Oscar Health
OSCR
$9.5B
| $10.6M | ﹤0.01% |
611,456
-52,745
| -8% | -$895K |
|
3608
iShares MSCI Poland ETF
EPOL
$813M
| $10.6M | ﹤0.01% |
484,704
-156,443
| -24% | -$3.46M |
|
|
FTH
3609
Faeth Therapeutics
FTH
$738M
| $10.5M | ﹤0.01% |
50,016
+31,843
| +175% | +$5.8M |
|
3610
Capital Bancorp
CBNK
$616M
| $10.5M | ﹤0.01% |
436,955
+4,826
| +1% | +$108K |
|
|
ME
3611
DELISTED
23andMe Holding Co
ME
| $10.5M | ﹤0.01% |
+57,854
| New | +$10.3M |
|
3612
State Street SPDR Portfolio TIPS ETF
SPIP
$1.01B
| $10.5M | ﹤0.01% |
336,472
+22,311
| +7% | +$701K |
|
|
INZY
3613
DELISTED
Inozyme Pharma
INZY
| $10.4M | ﹤0.01% |
900,719
+846
| +0.1% | +$13.2K |
|
3614
Biglari Holdings Class B
BH
$1.22B
| $10.4M | ﹤0.01% |
60,486
-3,235
| -5% | -$544K |
|
3615
Bioventus
BVS
$1.17B
| $10.4M | ﹤0.01% |
733,340
+293,206
| +67% | +$4.51M |
|
|
TIG
3616
DELISTED
Trean Insurance Group, Inc. Common Stock
TIG
| $10.3M | ﹤0.01% |
998,507
-8,415
| -0.8% | -$100K |
|
|
ONCR
3617
DELISTED
Oncorus, Inc.
ONCR
| $10.3M | ﹤0.01% |
1,105,449
-1,769
| -0.2% | -$20.2K |
|
3618
Neuronetics
STIM
$211M
| $10.3M | ﹤0.01% |
1,571,700
+45,723
| +3% | +$439K |
|
3619
DarioHealth
DRIO
$71.5M
| $10.3M | ﹤0.01% |
37,669
+858
| +2% | +$248K |
|
3620
Cameco
CCJ
$42.6B
| $10.2M | ﹤0.01% |
471,124
-6,685
| -1% | -$126K |
|
|
NOAC
3621
DELISTED
Natural Order Acquisition Corp. Common Stock
NOAC
| $10.2M | ﹤0.01% |
1,042,682
-90,308
| -8% | -$880K |
|
3622
InnovAge Holding
INNV
$1.45B
| $10.2M | ﹤0.01% |
1,547,084
+31,576
| +2% | +$489K |
|
3623
Skillsoft
SKIL
$78.4M
| $10.1M | ﹤0.01% |
43,373
+43,151
| +19,437% | +$8.38M |
|
|
JBIO
3624
Jade Biosciences
JBIO
$1.51B
| $10.1M | ﹤0.01% |
+13,801
| New | +$7.73M |
|
|
IACB.U
3625
DELISTED
ION Acquisition Corp 2 Ltd. Units, each consisting of one Class A ordinary share and one-eighth of o
IACB.U
| $10.1M | ﹤0.01% |
1,007,452
-18,998
| -2% | -$190K |
|
Similar funds
BlackRock's Q3 2021 Portfolio in Review
As of Q3 2021, BlackRock held 5,803 positions worth $3.57T, down 0.58% from $3.59T the previous quarter. Its ten largest holdings account for 19% of the portfolio.
BlackRock's Q3 2021 filing shows 283 new, 2,199 increased, 2,669 reduced and 164 closed positions. Its largest new stake was GXO Logistics: 8,566,775 shares worth $672M. The largest sale was Alexion Pharmaceuticals, an estimated $3.21B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q3 2021 buy was GXO Logistics: 8,566,775 shares worth $672M.
- BlackRock added most to Moderna in Q3 2021, an estimated $2.76B increase.
- BlackRock's biggest Q3 2021 reduction was Vanguard Short-Term Corporate Bond ETF, cutting an estimated $1.28B.
- BlackRock fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $3.21B.
- BlackRock's ten largest holdings make up 19% of its $3.57T portfolio in Q3 2021.
- BlackRock opened 283 new positions and closed 164 in Q3 2021.
- BlackRock's portfolio value fell 0.58% quarter-over-quarter to $3.57T.
Based on BlackRock's 13F filing for Q3 2021, filed 9 Nov 2021.